Award
NIH Reporter #5R01AG079241-05
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease
Recipient
University of Rhode Island
Award Amount
$2,002,901.00
Ceiling
$2,002,901.00
Awarded
May 28, 2026
Identifier
5R01AG079241-05
A federally funded research project by the University of Rhode Island to validate retinal biomarkers against cerebral imaging for early detection of Alzheimer's disease, involving longitudinal assessments over several years.
Description
This project aims to identify and validate retinal biomarkers for early detection of Alzheimer’s disease (AD) by comparing retinal imaging with standard brain imaging biomarkers such as MRI and PET scans. The study leverages the ARIAS infrastructure and includes longitudinal follow-up over three years with multiple imaging and cognitive assessments.